| Document |
Document Title |
|
WO/2020/084442A1 |
A system and method for testing the potency of a cannabis feedstock used in the manufacture of cannabis-infused foods and beverages are disclosed herein. The system and methods can include at least one sensor capable of detecting cannabi...
|
|
WO/2020/083971A2 |
The present invention relates to novel compounds of general formula (I) with A being A1 or A2, and in which T, X, Y, Ro, R1, R10 and R11 are as defined herein, methods of preparing said compounds, intermediate compounds useful for prepar...
|
|
WO/2020/084427A1 |
A system and a method for extracting one or more active compounds from a cannabis biomass are disclosed. The method comprises obtaining a raw biomass of cannabis plant. A prepared biomass may be obtained from the raw biomass and may be m...
|
|
WO/2020/086890A1 |
The invention provides novel co-crystals of epicatechin with a carboxy-N-heterocyclic co-crystal former such as trigonelline or proline and their pharmaceutical compositions. Methods of preparing the co-crystals and methods of using them...
|
|
WO/2020/084094A1 |
The present invention relates to a process for preparing a nitrated compound, comprising the step of reacting a compound (A) comprising at least one substituted or unsubstituted aromatic or heteroaromatic ring, wherein said heteroaromati...
|
|
WO/2020/084456A1 |
The present invention is method of using a smart patch, with analyte testing capabilities, to test a wearer's sweat for the levels of various cannabinoids and delivering at least one other cannabinoid to the user from a reservoir in the ...
|
|
WO/2020/078293A1 |
The present invention relates to the technical field of bioengineering and provides a method for efficient extraction of plant anthocyanidin. The method comprises steps of: hydrolyzing anthocyanin; using one of sodium bicarbonate or pota...
|
|
WO/2020/077428A1 |
The present invention describes compounds, the use of compounds in the preparation of a pharmaceutical composition, and a pharmaceutical composition comprising the compounds according to formula A, neutral or ionized derivatives or analo...
|
|
WO/2020/079106A1 |
The present invention provides novel compounds having the general formula (I) wherein R1 to R6, and m are as described herein, compositions including the compounds and methods of using the compounds.
|
|
WO/2020/077451A1 |
The disclosure relates to porous and non-porous silica capsules (capsules in capsule or core-shell capsules), porous microspheres, as well as their direct phase emulsification process without surfactant and their use, wherein the particl...
|
|
WO/2020/081108A1 |
The present disclosure is generally directed to methods for purifying cannabinoids from Cannabis plants.
|
|
WO/2020/077462A1 |
The present invention provides a powdered botanical extract preparation comprising an evenly distributed dispersion of a botanical extract in a methylsulfonylmethane matrix, processes for preparing the preparations, and dosage forms comp...
|
|
WO/2020/074453A1 |
The invention relates to a method for the chromatographic purification of at least one cannabinoid compound, wherein the method comprises a main purification stage comprising the steps of:injecting an initial mixture comprising the at le...
|
|
WO/2020/070088A1 |
The present invention provides novel compounds having the general formula (Formula I) : wherein R1 to R6, G1, G2, A1 to A4 and m are as described herein, compositions including the compounds and methods of using the compounds.
|
|
WO/2020/071550A1 |
The present invention provides a novel CDK8 inhibitor. The present invention relates to: a compound represented by general formula (I) (wherein the symbols are as defined in the description) or a pharmaceutically acceptable salt thereof;...
|
|
WO/2020/061703A1 |
The present disclosure relates to cannabinoid-containing product for human consumption having an improved taste profile and to methods of manufacturing same. The present disclosure also relates to a process for making a cannabinoid-conta...
|
|
WO/2020/061687A1 |
According to embodiments herein, pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions are provided. More specifically, a cannabis-based pharmaceutical composition and methods of ...
|
|
WO/2020/059768A1 |
The present invention provides a halogen compound that can be advantageously used for production of a 1,1-disubstituted hydrazine compound and preparation of a polymerizable compound. A compound according to the present invention is repr...
|
|
WO/2020/058339A1 |
Disclosed herein are novel coumarin-based reagents, e.g. linkers, and conjugates including one or more of the disclosed coumarin-based reagents. In some embodiments, the presence of a coumarin moiety within the coumarin-based reagents en...
|
|
WO/2020/052774A1 |
The application provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DNA) inhibitors.
|
|
WO/2020/053353A1 |
The invention relates to a method for producing S-arylthiocarbamates of general formula (I) by means of an electrochemically induced rearrangement of an O-arylthiocarbamate of general formula (II).
|
|
WO/2020/053249A1 |
The present invention provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DMA) inhibitors.
|
|
WO/2020/050462A1 |
The present invention relates to a naphthopyrone derivative and a composition comprising, as an active ingredient, a Cassia obtusifolia shoot extract including the naphthopyrone derivative. A composition according to an aspect of the pre...
|
|
WO/2020/047668A1 |
Provided herein are Myc-Max inhibitory compounds having the structure of Formula (I) and compositions thereof for use in the treatment of cancer. In particular, the Myc-Max inhibitory compounds may be useful for the treatment of cancers ...
|
|
WO/2020/051370A1 |
The identification and confirmation of 3 HTS hits with in vitro MEKK2 inhibitory activity using the MEKK2 ATPase HTS assay is shown. Preliminary SAR studies identified additional compounds for inhibiting MEKK2. Use of these compounds for...
|
|
WO/2020/051322A1 |
The present disclosure relates to a method of treating at least one condition selected from Cytokine Release Syndrome (CRS), Immune effector Cell-Associated Neurotoxicity Syndrome (ICANS), cancer-related cognitive impairment, Infusion Re...
|
|
WO/2020/044121A1 |
Described herein are cannabinoid formulations in combination with phenylalanine for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturin...
|
|
WO/2020/041871A1 |
This application is directed to the use of a ketogenic agent, such as 1,3-butanediol, R-β-hydroxybutyl-R-β-hydroxybutyrate, or triheptanoin, in the treatment of an individual having a lysosomal storage disease, including Pompe disease....
|
|
WO/2020/044123A1 |
Described herein are cannabinoid formulations in combination with Boswellia extract for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufact...
|
|
WO/2020/041860A1 |
An aqueous alkaline composition comprising a cannabinoid which may be cannabidiol (CBD) used alone or in combination with other cannabinoids. An alkalizing agent which comprises pico size carbon particles is present in the composition, i...
|
|
WO/2020/046822A1 |
A method for purification and separation of cannabinoids, such as cannabidiol and tetrahydrocannabinol, e.g., from dried hemp and cannabis leaves can use a continuous simulated moving bed process, a batch column chromatography method, or...
|
|
WO/2020/044116A1 |
Described herein are cannabinoid formulations in combination with curcumin for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof and manufacturing ora...
|
|
WO/2020/044118A1 |
Described herein are cannabinoid formulations for oral administration. Further described herein are methods for orally administering one or more cannabinoids to a subject in need thereof.
|
|
WO/2020/041877A1 |
Systems and methods of extracting compounds from botanical matter are provided. The system includes: a solvent source; an extraction vessel which receives botanical matter from which compounds, including at least one target compound are ...
|
|
WO/2020/037413A1 |
The present disclosure relates to a cannabinoid based emulsification system for infusing a non-aqueous composition with a cannabinoid, the emulsification system comprising: a) at least one cannabinoid in a carrier oil; b) a plurality of ...
|
|
WO/2020/040582A1 |
The present invention relates to a novel benzopyran derivative or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising same as an effective ingredient. Having no influence on the complex structure of HSP...
|
|
WO/2020/037410A1 |
The present disclosure relates to a cannabis-infused product, comprising an emulsion containing a cannabinoid profile including one or more cannabinoid, wherein the emulsion is a nanoemulsion. The disclosure also relates to methods of ma...
|
|
WO/2020/037409A1 |
The present disclosure relates to a cannabis-infused product comprising a cannabinoid profile including one or more cannabinoid, a first composition for controlling onset of the cannabinoid profile and a second composition for extending ...
|
|
WO/2020/037412A1 |
The present disclosure relates to a cannabinoid based dry or aqueous self-emulsification system for infusing a composition with a cannabinoid. The self-emulsification system comprises: a) at least one cannabinoid in a carrier oil; b) a p...
|
|
WO/2020/037402A1 |
A dosage device that includes a cannabinoid-containing substance enables controlled addition of the cannabinoid-containing substance to a liquid to produce a cannabinoid-containing liquid for ingestion. In an embodiment, such a dosage de...
|
|
WO/2020/037408A1 |
The present disclosure relates to a cannabis-infused product comprising a cannabinoid profile including one or more cannabinoid, a first composition for controlling onset of the cannabinoid profile and a second composition for controllin...
|
|
WO/2020/035601A1 |
The present invention relates to a process for the production of chromanol and 2-methyl-1,4-naphthoquinone derivatives, more specifically to a process for preparing a compound of the general formula (I) or (II) wherein the variables are ...
|
|
WO/2020/035058A1 |
Disclosed are a class of pharmaceutical compounds for treating liver diseases and application thereof. In particular, said pharmaceutical compounds are compounds as represented by general formula (I), optical isomers, or pharmaceutically...
|
|
WO/2020/035604A1 |
The present invention relates to a process for the production of chromanol derivatives, more specifically to a process for preparing a compound of the general formula I wherein R1, R2 and R3 independently of each other are selected from ...
|
|
WO/2020/035600A1 |
The present invention relates to a process for the production of chromanol derivatives, more specifically to a process for preparing a compound of the general formula (I) wherein R1, R2 and R3 independently of each other are selected fro...
|
|
WO/2019/008537A9 |
There is provided a medical compound comprising a synthetic flavone derivative, according to the formula (I) with allotment in position C-3 of a group as shown below: Formula (I) wherein at least two of R2-R6 a re H, and the remaining ar...
|
|
WO/2020/028991A1 |
The invention relates to methods for producing botanical extracts comprising cannabinoids and terpenes using cold extraction with highly polyunsaturated lipid solvents. These methods allow for the extraction of cannabinoids and terpenes ...
|
|
WO/2020/032913A1 |
Disclosed is a novel, simple, scalable and environment friendly process for the synthesis of Oroxylin A from Baicalin. Baicalm is esterified to obtain a methyl ester which is further selectively methylated to provide Oroxylin A gluciiron...
|
|
WO/2020/028992A1 |
The invention relates to methods of producing extracts from cannabis plant material, where the extracts comprise cannabinoids and terpenes. The methods comprise extracting fresh or dried plant material with a cold organic solvent. The me...
|
|
WO/2020/031179A1 |
The present invention provides simple synthetic routes for the preparation of cannabinoid compounds such as CBD, CBDV, THC, THCV, CBN, HU-308, CBG, CBC, and derivatives thereof, which are stereoselective and provide the desired cannabino...
|
